These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24836379)

  • 21. An approximate unconditional test of non-inferiority between two proportions.
    Kang SH; Chen JJ
    Stat Med; 2000 Aug; 19(16):2089-100. PubMed ID: 10931513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-sample adjustments in using the sandwich variance estimator in generalized estimating equations.
    Pan W; Wall MM
    Stat Med; 2002 May; 21(10):1429-41. PubMed ID: 12185894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and analysis of three-arm trials with negative binomially distributed endpoints.
    Mütze T; Munk A; Friede T
    Stat Med; 2016 Feb; 35(4):505-21. PubMed ID: 26388314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Power analyses for negative binomial models with application to multiple sclerosis clinical trials.
    Rettiganti M; Nagaraja HN
    J Biopharm Stat; 2012; 22(2):237-59. PubMed ID: 22251172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian estimation of intervention effect with pre- and post-misclassified binomial data.
    Stamey JD; Seaman JW; Young DM
    J Biopharm Stat; 2007; 17(1):93-108. PubMed ID: 17219757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sample size determination for logistic regression revisited.
    Demidenko E
    Stat Med; 2007 Aug; 26(18):3385-97. PubMed ID: 17149799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    Biom J; 2007 Aug; 49(4):613-26. PubMed ID: 17634977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wald tests for variance-adjusted equivalence assessment with normal endpoints.
    Chen YM; Weng YT; Dong X; Tsong Y
    J Biopharm Stat; 2017; 27(2):308-316. PubMed ID: 27906607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stratified tests, stratified slopes, and random effects models for clinical trials with missing data.
    Dawson JD; Han SH
    J Biopharm Stat; 2000 Nov; 10(4):447-55. PubMed ID: 11104386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-sample performance of the robust score test and its modifications in generalized estimating equations.
    Guo X; Pan W; Connett JE; Hannan PJ; French SA
    Stat Med; 2005 Nov; 24(22):3479-95. PubMed ID: 15977302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Odds ratio for 2 × 2 tables: Mantel-Haenszel estimator, profile likelihood, and presence of surrogate responses.
    Banerjee B; Biswas A
    J Biopharm Stat; 2014; 24(3):649-59. PubMed ID: 24697719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sample size computation for two-sample noninferiority log-rank test.
    Jung SH; Kang SJ; McCall LM; Blumenstein B
    J Biopharm Stat; 2005; 15(6):969-79. PubMed ID: 16279355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
    Friede T; Kieser M
    Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shrinkage estimation of effect sizes as an alternative to hypothesis testing followed by estimation in high-dimensional biology: applications to differential gene expression.
    Montazeri Z; Yanofsky CM; Bickel DR
    Stat Appl Genet Mol Biol; 2010; 9():Article23. PubMed ID: 20597849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-regional clinical trial design and consistency assessment of treatment effects.
    Quan H; Mao X; Chen J; Shih WJ; Ouyang SP; Zhang J; Zhao PL; Binkowitz B
    Stat Med; 2014 Jun; 33(13):2191-205. PubMed ID: 24515845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New tests for null hypothesis of non unity ratio of proportions.
    Koti KM
    J Biopharm Stat; 2007; 17(2):229-45. PubMed ID: 17365220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Power and sample size determination for noninferiority trials using an exact method.
    Chan IS
    J Biopharm Stat; 2002 Nov; 12(4):457-69. PubMed ID: 12477069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.